Story via Health Canal
Researchers at the Monash Institute of Pharmaceutical Sciences (MIPS) developed a novel drug delivery technology - it has been acquired by Capsugel, a global leader in innovative dose-form development.
Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquid Technology developed by researchers at MIPS led by Professors Chris Porter and Peter Scammells. The novel technology uses lipid-like counter-ions to transform crystalline drugs into ionic liquids. This leads to significant increases in drug solubility in lipid-based liquid, semi-solid and multiparticulate formulations.
MIPS researchers has a long history of collaboration with Capsugel in lipid-based drug delivery science. This includes co-founding the Lipid Formulation Classification System (LFCS) Consortium to advance and standardise evaluation protocols for lipid-based drug-delivery systems.
Professor Bill Charman, Director of the Monash Institute of Pharmaceutical Sciences, said "we are thrilled to partner with Capsugel to advance the development of the Ionic Liquids Technology and to accelerate our current and future collaborative drug-delivery projects,”.
Keith Hutchison, PhD, Senior Vice President, Research & Development, Capsugel said: “Our partnership with MIPS demonstrates Capsugel’s commitment to advancing high-caliber science for improved drug delivery and better healthcare solutions. The Ionic Liquids Technology will allow us to significantly increase drug solubility, reduce absorption variability, decrease excipient levels and reduce pill burden. This represents a valuable addition to our capabilities in designing and developing innovative immediate and modified-release dosage forms. Our continuing work with Monash holds great potential for additional drug-delivery innovations in the future.”
Want to be in a partnership like MIPS and Capsugel? The 19th Annual Drug Delivery Partnerships is just the place to find a suitable partner. At DDP, accelerate your path to market by leveraging new partnerships, breakthrough innovation and unique business models. Don't miss this event!